The uptick in demand for nanotechnology practices that can solve several genetic-related diseases has increased of late. The multiplex assays market is expected to reach USD 3.11 Billion an approximate CAGR of 6.80% during the forecast period (2022-2030).The market for multiplex arrays is advancing due to the increased funding and research being diverted to the market. Increased awareness of the benefits of multiplex assays is fuelling the growth of the market over the forecast period. The multifactorial nature of several diseases and
Jun88
Huang Haynes
Vijay Nilevar
Xxxpg
Link Kjellerup
Owens Downey
Webster Rush
Bjerre Henry
Kelly Aggerholm
P80 Bet